June 13, 2025

RSV Vaccine Approved for Younger Adults

The FDA has approved Moderna’s mRESVIA vaccine for adults aged 18 to 59 who are at increased risk for RSV, expanding its indication beyond older adults.

Conexiant

June 13, 2025

Endoscopic Sinus Surgery Speeds Recovery

A retrospective study comparing endoscopic and traditional open sinus surgery for chronic rhinosinusitis with nasal polyps found shorter operative times, fewer complications, and improved outcomes associated with the endoscopic technique.

Conexiant

June 12, 2025

Smoking Cessation Drugs Show No Birth Risk

A large multinational cohort study found no increased risk of major congenital malformations associated with nicotine replacement therapy, varenicline, or bupropion use during early pregnancy.

Conexiant

June 09, 2025

New Fixed-Dose RSV Antibody Approved

The FDA has approved enflonsia, a fixed-dose monoclonal antibody, for preventing RSV lower respiratory tract disease in infants during their first season.

Conexiant

June 09, 2025

Gray and Blazed: Pot’s Risky New Demographic

As cannabis use rises among older adults, new studies reveal surprising health risks—from ER visits to potential dementia links.

KFF Health News

June 06, 2025

RSV or COVID: Which Strains the Heart?

A study of 32,960 hospitalizations finds 10.9% of patients with RSV experienced acute cardiovascular events, with significantly higher adjusted odds than boosted and unboosted COVID-19 cases.

Conexiant

June 04, 2025

Big Tobacco's Medical Research Infiltrates Journals

Investigation reveals tobacco-funded studies appear in top medical journals despite industry bans, as companies invest billions in pharmaceutical subsidiaries.

Conexiant

June 03, 2025

FDA Grants Breakthrough Status to Shield Test

The methylation-based blood assay is designed for screening multiple cancer types.

Conexiant

June 02, 2025

New COVID Vaccine Approved for High-Risk Groups

After showing higher efficacy and a comparable safety profile to Spikevax, the FDA has approved Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk patients.

Conexiant